Skip to content

Clinical trials

Phase 2 Hyperandrogenism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperandrogenism Phase: Phase 2 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20132
20152
20171
20181
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karolinska Institutet1
Milton S. Hershey Medical Center1
National Center for Research Resources (NCRR)1
National Institutes of Health Clinical Center (CC)1
Novartis Pharmaceuticals1
Poznan University of Medical Sciences1
Semnan University of Medical Sciences1
University of California, Los Angeles1
University of Illinois at Chicago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperandrogenism9
Polycystic Ovary Syndrome6
Insulin Resistance4
Anovulation3
Inflammation2
Adrenal Hyperplasia, Congenital1
Adrenal Insufficiency1
Amenorrhea1
Endocrine System Diseases1
Glucose Intolerance1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.